The Absolute Bioavailability and Metabolic Disposition of the Novel Antimigraine Compound Zolmitriptan (311C90)

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1046/j.1365-2125.1997.00614.x

Related search